Tomoiaga, Delia
Aguiar-Pulido, Vanessa
Shrestha, Shristi
Feinstein, Paul
Levy, Shawn E. http://orcid.org/0000-0002-1369-5740
Mason, Christopher E. http://orcid.org/0000-0002-1850-1642
Rosenfeld, Jeffrey A. http://orcid.org/0000-0002-8750-2841
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (2P30-CA072720-20)
Article History
Received: 29 August 2019
Accepted: 2 January 2020
First Online: 21 February 2020
Competing interests
: C.E.M. is a cofounder and board member for Biotia and Onegevity Health, as well as an advisor or compensated speaker for Abbvie, Acuamark Diagnostics, ArcBio, BioRad, DNA Genotek, Genialis, Genpro, Karius, Illumina, New England Biolabs, QIAGEN, Whole Biome and Zymo Research. D.T., J.A.R. and C.E.M. have a related U.S. Patent application 62/460,480. The remaining authors declare that there are no competing interests.